Search

Sonova Holding AG

Suletud

SektorTervishoid

210.1 -0.38

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

207

Max

211.7

Põhinäitajad

By Trading Economics

Sissetulek

-255M

189M

Müük

-217M

1.8B

P/E

Sektori keskmine

23.812

88.032

Aktsiakasum

3.16

Dividenditootlus

2.14

Kasumimarginaal

10.389

Töötajad

18,035

EBITDA

-128M

382M

Soovitused

By TipRanks

Soovitused

Müü

12 kuu keskmine prognoos

-1.24% downside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.14%

2.26%

Turustatistika

By TradingEconomics

Turukapital

238M

12B

Eelmine avamishind

210.48

Eelmine sulgemishind

210.1

Uudiste sentiment

By Acuity

34%

66%

98 / 373 Pingereas Healthcare

Sonova Holding AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. sept 2025, 13:05 UTC

Suurimad hinnamuutused turgudel

European Med-Tech Stocks Fall After U.S. Opens Import Probe

Sonova Holding AG Prognoos

Hinnasiht

By TipRanks

-1.24% langus

12 kuu keskmine prognoos

Keskmine 207.5 CHF  -1.24%

Kõrge 250 CHF

Madal 147.001 CHF

Põhineb 9 Wall Streeti analüütiku instrumendi Sonova Holding AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

9 ratings

1

Osta

3

Hoia

5

Müü

Sentiment

By Acuity

98 / 373 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.
help-icon Live chat